The seventh tumour-node-metastasis staging system for lung cancer: Sequel or prequel?

European Journal of Cancer, Supplement

Volumn 11, Issue 2, 2013, Pages 150-158

  van Meerbeeck, Jan P ^a   Janssens, Annelies ^a  

^a ANTWERP UNIVERSITY HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER PROGNOSIS; CANCER REGISTRY; CANCER STAGING; CARCINOID; CLINICAL ASSESSMENT; CONFERENCE PAPER; DISEASE SEVERITY; GOLD STANDARD; HUMAN; JAPANESE; LUNG CANCER; LUNG NON SMALL CELL CANCER; LUNG RESECTION; LUNG SMALL CELL CANCER; MEDIASTINUM LYMPH NODE; PERINEURAL INVASION; PRIORITY JOURNAL; RADIOLOGIST; THORAX SURGERY; UNITED KINGDOM; UNITED STATES;

EID: 84884952067     PISSN: 13596349     EISSN: 18781217     Source Type: Journal    
DOI: 10.1016/j.ejcsup.2013.07.025     Document Type: Conference Paper

References (71)

1. TNM classification of malignant tumours 1968, International Union Against Cancer (UICC), Geneva, Switzerland. 1st ed.
2. Salzer G. Vorschlag einer Einteilung des bronchuskarzinoms nach pathologisch-anatomisch-klinischen Gesichtspunkten. Wien Med Wochenschr 1951, 5(6):102-103.
3. Nohl H.C. Three year follow up of classified cases of bronchogenic carcinoma after resection. Thorax 1960, 15:11-16.
4. Zelen M. Keynote address on biostatistics and data retrieval. Cancer Chemother Rep 1973, 4:31-42.
5. Mountain C.F., Carr D.T., Anderson W.A. A system for the clinical staging of lung cancer. Am J Roentgenol Radium Ther Nucl Med 1974, 120:130-138.
6. TNM classification of malignant tumours 1975, International Union Against Cancer (UICC), Geneva, Switzerland. 2st ed.
7. American Joint Committee on Cancer Staging and End Results Reporting: AJC Cancer Staging Manual. 1st ed. Philadelphia, PA: Lippincott-Raven; 1977.
8. Mountain C.F. A new international staging system for lung cancer. Chest 1986, 89(Suppl. 4):225S-232S.
9. TNM classification of malignant tumours 1987, Springer Verlag, Berlin, Germany. 4th ed. P. Hermanek, L.H. Sobin (Eds.).
10. Manual for Staging of Cancer 1988, JB Lippincott, Philadelphia, PA. 3th ed. O.H. Beahrs, D.E. Henson, R.O. Hutter (Eds.).
11. Mountain C.F. Revisions in the international system for staging lung cancer. Chest 1997, 111:1710-1717.
12. UICC TNM Classification of Malignant Tumours 2002, Wiley-Liss, New York, NY. 6th ed. L.H. Sobin, C. Wittekind (Eds.).
13. AJCC Cancer Staging Manual 2002, Springer, New York, NY. 6th ed. F.L. Greene, D.L. Page, I.D. Fleming (Eds.).
14. Mountain C.F., Dresler C.M. Regional lymph node classification for lung cancer staging. Chest 1997, 111:1718-1723.
15. Naruke T., Suemasu K., Ishikawa S. Lymph node mapping and curability at various levels of metastasis in resected lung cancer. J Thorac Cardiovasc Surg 1978, 76:832-839.
16. Goldstraw P., Crowley J. The IASLC international staging project on lung cancer. J Thorac Oncol 2006, 1:281-286.
17. Goldstraw P. IASLC staging handbook in thoracic oncology 2009, EditorialRx Press, Orange Park, FL. 1st ed.
18. AJCC cancer staging handbook 2009, Springer, New York, NY. 7th ed. S.B. Edge, D.R. Byrd, C.C. Compton (Eds.).
19. UICC TNM Classification of Malignant Tumours 2009, Wiley-Liss, New York, NY. 7th ed. L.H. Sobin, M.K. Gospodarowicz, C. Wittekind (Eds.).
20. Detterbeck F., Boffa D.J., Tanoue L.T. The new lung cancer staging system. Chest 2009, 136:260-271.
21. Goldstraw P. New staging system: how does it affect our practice?. J Clin Oncol 2013, 31:984-991.
22. Rami-Porta R., Ball D., Crowley J., et al. The IASLC lung cancer staging project: proposals for the revision of the T descriptors in the forthcoming (seventh) edition of the TNM classification for lung cancer. J Thorac Oncol 2007, 2:593-602.
23. Goldstraw P., Crowley J., Chansky K., et al. The IASLC lung cancer staging project: proposals for revision of the stage groupings in the forthcoming (seventh) edition of the TNM classification for lung cancer. J Thorac Oncol 2007, 2:706-714.
24. Martini N., Melamed M.R. Multiple primary lung cancers. J Thorac Cardiovasc Surg 1975, 70:606-612.
25. Antakli T., Schaefer R.F., Rutherford J.E., et al. Second primary lung cancer. Ann Thorac Surg 1995, 59:863-866.
26. Postmus P.E., Brambilla E., Chansky K., et al. The IASLC lung cancer staging project: proposals for revision of the M descriptors in the forthcoming (seventh) edition of the TNM classification for lung cancer. J Thorac Oncol 2007, 2:686-693.
27. Rusch V.R., Crowley J., Giroux D.J., et al. The IASLC Lung Cancer Staging Project: proposals for revision of the N descriptors in the forthcoming (seventh) edition of the TNM classification for lung cancer. J Thorac Oncol 2007, 2:603-612.
28. Rusch V., Asamura H., Watanabe H., et al. The IASLC lung cancer staging project: a proposal for a new international node map in the forthcoming seventh edition of the TNM classification for lung cancer. J Thorac Oncol 2009, 4:568-577.
29. Watanabe Y. TNM classification for lung cancer. Ann Thorac Cardiovasc Surg 2003, 9:343-350.
30. Osarogiagbon R.U., Allen J.W., Farooq A., et al. Objective review of mediastinal lymph node examination in a lung cancer resection cohort. J Thorac Oncol 2012, 7:390-396.
31. Wright G., Manser R.L., Byrnes G., et al. Surgery for non-small cell lung cancer: systematic review and meta-analysis of randomised trials. Thorax 2006, 61:597-603.
32. Watanabe Si, Asamura H. Lymph node dissection for lung cancer: significance, strategy and technique. J Thorac Oncol 2009, 4:652-657.
33. Gajra A., Newman N., Gamble G.P., et al. Effect of number of lymph nodes sampled on outcome in patients with stage I non-small-cell lung cancer. J Clin Oncol 2003, 21:1029-1034.
34. Rami-Porta R., Wittekind C. Goldstraw P for the international association for the study of lung cancer (IASLC) staging committee. Complete resection in lung cancer surgery: proposed definition. Lung Cancer 2005, 49:25-33.
35. Shepherd F.A., Crowley J., Van Houtte P., et al. The IASLC lung cancer staging project: proposals regarding the clinical staging of small-cell lung cancer in the forthcoming (seventh) edition of the TNM classification for lung cancer. J Thorac Oncol 2007, 2:1067-1077.
36. Vallières E., Shepherd F.A., Crowley J., et al. The IASLC lung cancer staging project: proposals regarding the relevance of TNM in the pathological staging of small-cell lung cancer in the forthcoming (seventh) edition of the TNM classification for lung cancer. J Thorac Oncol 2009, 4:1049-1059.
37. Travis W.D., Giroux D.J., Chansky K., et al. The IASLC lung cancer staging project: proposals for the inclusion of carcinoid tumours in the forthcoming (seventh) edition of the TNM classification for lung cancer. J Thorac Oncol 2008, 3:1213-1223.
38. Travis W.D., Brambilla E., Rami-Porta R., et al. Visceral pleural invasion: pathologic criteria and use of elastic stains-proposals for the 7th edition of the TNM classification for lung cancer. J Thorac Oncol 2008, 3:1384-1390.
39. Japan lung cancer society classification of lung cancer, English 2000, Kanehara, Tokyo, Japan. 1st ed. H. Kato (Ed.).
40. Hammar SP. In: Dail DH, Hammar SP, editors. Pulmonary pathology, common tumours. 2nd ed. Springer-Verlag: New York, NY; 1994.
41. Kudo Y., Saji H., Shimada Y., et al. Impact of visceral pleural invasion on the survival of patients with non-small celllung cancer. Lung cancer 2012, 78:153-160.
42. Van Meerbeeck J.P., Chansky K., Goldstraw P. The impact of stage migration on survival after resection in the UICC 7 TNM-classification of lung cancer. J Clin Oncol 2010, 28:15s. (suppl; abstract 7022).
43. Strand T.E., Rostad H., Wentzel-Larsen T., von Plessen C. A population-based evaluation of the seventh edition of the TNM system for lung cancer. ERJ 2010, 36:401-407.
44. Groome P.A., Bolejack V., Crowley J.J., et al. The IASLC lung cancer staging project: validation of the proposals for revision of the T, N and M descriptors and consequent stage groupings in the forthcoming (seventh) TNM classification for lung cancer. J Thorac Oncol 2007, 2:694-705.
45. Ou S.H., Zell J.A. Validation study of the proposed IASLC staging revisions of the T4 and M non-small cell lung cancer descriptors using data from 23,583 patients in the California Cancer Registry. J Thorac Oncol 2008, 3:216-227.
46. Sawabata N., Miyaoka E., Asamura H., et al. For the japanese joint committee for lung cancer registration. Japanese lung cancer registry study of 11,663 surgical cases in 2004: demographic and prognosis changes over decade. J Thorac Oncol 2004, 2011(6):1229-1235.
47. Tournoy K.G., Annema J.T., Krasnik M., Herth F.J., van Meerbeeck J.P. Endoscopic and endobronchial ultrasonography according to the proposed lymph node map definition in the seventh edition of the tumour, node, metastasis classification for lung cancer. J Thorac Oncol 2009, 4:1576-1584.
48. Aberle D.R., Adams A.M., Berg C.D., et al. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 2011, 365:395-409.
49. Ou S.H., Zell J.A., Ziogas A., Anton-Culver H. Prognostic significance of the non-size-based AJCC T2 descriptors: visceral pleura invasion, hilar atelectasis, or obstructive pneumonitis in stage IB non-small cell lung cancer is dependent on tumour size. Chest 2008, 133:662-669.
50. Detterbeck F.C., Boffa D.J., Tanoue L.T., Wilson L.D. Details and difficulties regarding the new lung cancer staging system. Chest 2010, 137:1172-1180.
51. De Wever W., Ceyssens S., Mortelmans L., et al. Additional value of PET-CT in the staging oflung cancer: comparison with CT alone, PET alone and visual correlation of PET and CT. Eur Radiol 2007, 17:23-32.
52. Feinstein A.R., Sosin D.M., Wells C.K. The Will Rogers phenomenon. Stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer. N Engl J Med 1985, 312:1604-1608.
53. Morgensztern D., Goodgame B., Baggstrom M.Q., Gao F., Govindan R. The effect of FDG-PET on the stage distribution of non-small cell lung cancer. J Thorac Oncol 2008, 3:135-139.
54. Chee K.G., Nguyen D.V., Brown M., et al. Positron emission tomography and improved survival in patients withlung cancer: the Will Rogers phenomenon revisited. Arch Intern Med 2008, 168:1541-1549.
55. Gregory D.L., Hicks R.J., Hogg A., et al. Effect of PET/CT on management of patients with non-small cell lung cancer: results of a prospective study with 5-year survival data. J Nucl Med 2012, 53:1007-1015.
56. Van Meerbeeck J.P., Nicholson M., Gilligan D., et al. Adjuvant or neoadjuvant chemotherapy in early-stage non-small cell lung cancer (NSCLC): how would staging affect the patients treated?. J Clin Oncol 2008, 26. (suppl; abstract 7509).
57. Pignon J.P., Tribodet H., Scagliotti G.V., et al. Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE Collaborative Group. J Clin Oncol 2008, 26:3352-3359.
58. Strauss G.M., Herndon J.E., Maddaus M.A., et al. Adjuvant paclitaxel plus carboplatin compared with observation in stage IB non-small cell lung cancer: CALGB 9633 with the Cancer and Leukemia Group B, Radiation Therapy Oncology Group, and the North Central Cancer Treatment Group Study Groups. J Clin Oncol 2008, 26:5043-5051.
59. Cuffe S., Bourredjem A., Graziano S., et al. A pooled exploratory analysis of the effect of tumour size and KRAS mutations on survival benefit from adjuvant platinum-based chemotherapy in node-negative non-small cell lung cancer. J Thorac Oncol 2012, 7:963-972.
60. Giroux D.J., Rami-Porta R., Chansky K., et al. The IASLC lung cancer staging project: data elements for the prospective project. J Thorac Oncol 2009, 4:679-683.
61. Travis W.D., Brambilla E., Noguchi M., et al. International association for the study of lung cancer/American thoracic society/European respiratory society international multidisciplinary classification of lung adenocarcinoma. J Thorac Oncol 2011, 6:244-285.
62. Asamura H. Clinical application of new (7th TNM staging system for lung cancer. J Thor, Oncol 2012, 7S5:S442.
63. Lim E., Clough R., Goldstraw P., et al. Impact of positive pleural lavage cytology on survival in patients undergoing lung resection for non-small cell lung cancer: an international individual patient data meta-analysis. J Thorac Cardiovasc Surg 2010, 139:1441-1446.
64. Hermanek P., Hutter R.V.P., Sobin L.H., Wittekind C. Classification of isolated tumour cells and micrometastases. Cancer 1999, 86:2668-2673.
65. Hiltermann T.J., Pore M.M., van den Berg A., et al. Circulating tumour cells in small-celllung cancer: a predictive and prognostic factor. Ann Oncol 2012, 23:2937-2942.
66. Sculier J.P., Chansky K., Crowley J.J., Van Meerbeeck J., Goldstraw P. The impact of additional prognostic factors on survival and their relationship with the anatomical extent of disease expressed by the 6th Edition of the TNM Classification of Malignant Tumors and the proposals for the 7th Edition. J Thorac Oncol 2008, 3:457-466.
67. Kim AW, Johnson KM, Detterbeck FC. < [accessed 29.04.2013]. http://www.stagingLungCancer.org.
68. Anonymous. < [accessed 29.04.2013]. http://www.predictcancer.org.
69. Silvestri G.A. A seismic shift in staging. J Thorac Oncol 2007, 2:682-683.
70. Detterbeck F. Lumping, splitting and sorting. J Thorac Oncol 2007, 2:581-582.
71. Colice G. Lung cancer staging and the home insurance building constructed in 1884-1885. Chest 2009, 136:6-8.